Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-068828)

Filing Details

Accession Number:: 0001209191-14-068828
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-14 16:05:16
Reporting Period:: 2014-11-12

Filing Date:: 2014-11-14
Accepted Time:: 2014-11-14 16:05:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1505512	Regulus Therapeutics Inc.	RGLS	Pharmaceutical Preparations (2834)	264738379

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901832	Plc Astrazeneca	2 Kingdom Street London X0 W2 6BD		No	No	Yes	No
928966	Ab Astrazeneca	85 Sodertalje V7 SE-151		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-11-12	2,000,000	$17.00	4,250,000	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote

Footnotes

The securities are owned directly by AstraZeneca AB, a wholly-owned, indirect subsidiary of AstraZeneca PLC. AstraZeneca PLC is an indirect beneficial owner of the reported securities.